FindTrial
Sign In

Significance of biomarkers Serum Adiponectin and Sex-Hormone Binding Globulin for Predicting Diabetes Mellitus Early in Pregnancy

Utility of Serum Adiponectin and Sex-Hormone Binding Globulin in Early Prediction of Gestational Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106826
Enrollment
300
Registered
2026-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Nitte University NURF fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with singleton pregnancy below 16weeks of gestation.Those who complete prenatal care and deliver the baby in our institution will be included in the study analysis.

Exclusion criteria

Exclusion criteria: Multiple gestation,Preexisting type I and Type II diabetes mellitus,Pre-existing Hypertension,Chronic medical disease like renal failure, liver failure,Presence of active infection,Confirmed cases of foetal malformations or chromosomal abnormality.

Design outcomes

Primary

MeasureTime frame
To evaluate the utility of plasma Adiponectin and Sex-Hormone-Binding Globulin (SHBG) for early prediction of gestational diabetes mellitus (GDM)Timepoint: From the entry point in first trimester until glucose challemge test performed between 24 to 28 weeks for GDM diagnosis—

Secondary

MeasureTime frame
To study the association between plasma levels of Adiponectin, SHBG, Insulin, C-peptide & complications related to GDM. To study the association between plasma levels of Adiponectin, SHBG, Insulin, C-peptide & medication requirements in GDM.Timepoint: Baseline visit in 1st trimester, 24-28weeks gestation age, immediate post partum prior to discharge from hospital—

Countries

India

Contacts

Public ContactDr Akhila Bhandarkar

KS Hegde Medical Academy

drakhila.bhandarkar@gmail.com9971508069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026